Dr. Philip Wong, MD

Dr. Wong practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Wong's NPI, 1932168267, was assigned on March 23, 2006. Dr. Wong graduated from New York Medical College in 1996. Dr. Wong holds Florida license ME132157.

Dr. Wong's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Wong's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Wong is also affiliated with Cape Coral Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Wong to 2 more hospitals, 2 medical groups, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wong practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Wong's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Wong is board certified in urology by the American Board of Urology. Dmand AI has Dr. Wong's licenses on file in 3 states: Florida, Texas and Massachusetts.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and testicular dysfunction among the conditions Dr. Wong treats.

CMS data shows 3,138 Medicare services from Dr. Wong across 20 procedure codes in 2024, for 564 Medicare patients. Medicare paid $176,777 for them.

CMS counts 564 Medicare patients who saw Dr. Wong in 2024. The largest group is 75 to 84, with 254 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wong's median patient age at 75, with 22% women.

In 2024, Dr. Wong wrote 2,100 Medicare Part D claims for 590 patients. 95% of them were for generic drugs. CMS names the drug for 1,961 of them, across 20 drugs with 11 or more claims each, at $72,634 in total drug cost. In 2023, CMS named 2,108 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Wong for performance year 2024, reported individually. Dr. Wong accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wong as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Wong, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Wong. Dr. Wong's most frequent co-authors are Kisseng Hsieh, MD and Joseph Chihping Liao, MD.

CMS Open Payments shows 166 general payments to Dr. Wong from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Endo Pharmaceuticals Inc. paid the most, $552.

Dmand AI lists 1 award for Dr. Wong.

Dr. Wong graduated from New York Medical College in 1996. Dr. Wong is a member of ACS and SLS.

Dr. Wong is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.